Reference:
Palmer, M., & Bhakdi, S. (2021). Long-term persistence of the SARS-CoV-2 spike protein: Evidence and implications. doctors4covidethics.org.
Summary:
The article by Palmer and Bhakdi discusses a study by Bansal et al. that reveals the prolonged presence of the SARS-CoV-2 spike protein in individuals vaccinated with the Pfizer mRNA vaccine. It highlights that the spike protein can be detected on exosomes for at least four months post-vaccination, raising concerns about potential long-term inflammation and organ damage. The authors contrast these findings with earlier studies that showed a shorter duration of spike protein expression. They also address the immune response dynamics, noting that the presence of antibodies could interfere with the detection of spike protein. The paper suggests that persistent spike protein expression may lead to ongoing immune activation, contributing to inflammation and related health issues. Furthermore, it questions the completeness of safety data from Pfizer’s clinical trials, given the extended duration of spike protein presence compared to trial observation periods.